Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sabrina de Munnik"'
Autor:
Gemma Moiset, Sophie Vermond, Monique Hazenoot, Rene McLaughlin, Sabrina de Munnik, Marco Guadagnoli, Sanne Holt, Marijn Vlaming
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d87669392ddd46b18ce37510d23d849f
Autor:
Gemma Moiset, Sophie Vermond, Monique Hazenoot, Rene McLaughlin, Sabrina de Munnik, Marco Guadagnoli, Marijn Vlaming, Sann Holt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ea383c9993774934b82c985557612dba
Autor:
Ellen V Langemeijer, Erik Slinger, Sabrina de Munnik, Andreas Schreiber, David Maussang, Henry Vischer, Folkert Verkaar, Rob Leurs, Marco Siderius, Martine J Smit
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48935 (2012)
Chronic activation of Wnt/β-catenin signaling is found in a variety of human malignancies including melanoma, colorectal and hepatocellular carcinomas. Interestingly, expression of the HCMV-encoded chemokine receptor US28 in intestinal epithelial ce
Externí odkaz:
https://doaj.org/article/dc6c07a9a5084249b47881e5dc3e6aaf
Autor:
Meritxell Canals, Danny J Scholten, Sabrina de Munnik, Mitchell K L Han, Martine J Smit, Rob Leurs
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34192 (2012)
The chemokine receptor CXCR7 binds CXCL11 and CXCL12 with high affinity, chemokines that were previously thought to bind exclusively to CXCR4 and CXCR3, respectively. Expression of CXCR7 has been associated with cardiac development as well as with tu
Externí odkaz:
https://doaj.org/article/7a20179af6284c509d08af9f5b2ad276
Autor:
Sophie Vermond, Benita Quist, Monique Hazenoot, Rene McLaughlin, David Cobeta Lopez, Namrata Jayanth, Folkert Verkaar, Omar Aziz, Maria LH Vlaming, Sabrina de Munnik, Gemma Moiset
Publikováno v:
Cancer Research. 83:4058-4058
Engineered T cell therapies such as Chimeric Antigen Receptor (CAR) T cells and T cell receptor (TCR)-engineered T cells have emerged as a promising cancer therapy. To date, four anti-CD19 CAR-T and two anti-BCMA CAR-T products have been approved by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0214e862d09395726f28b1f691e7b6fd
https://doi.org/10.1158/1538-7445.am2023-4058
https://doi.org/10.1158/1538-7445.am2023-4058
Autor:
Marco Guadagnoli, Monique Hazenoot, Gemma Moiset, Sann Holt, Sophie Vermond, Sabrina de Munnik, Rene McLaughlin, Marijn Vlaming
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCell therapies such as Chimeric Antigen Receptor T cells (CAR-T) and T Cell Receptor (TCR) T cells are immune-therapeutic approaches showing great momentum in research and the clinic. To date, four anti-CD19 CAR-T products and one anti-BCMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45983a689c0afa5573d6650161c84f87
https://doaj.org/article/ea383c9993774934b82c985557612dba
https://doaj.org/article/ea383c9993774934b82c985557612dba
Autor:
Sophie Vermond, Benita Quist, Sabrina de Munnik, Monique Hazenoot, Madalina Avramescu, Rene McLaughlin, Gemma Moiset, Marijn Vlaming
Publikováno v:
Cancer Research. 82:5576-5576
Engineered T cell therapies such as Chimeric Antigen Receptor T cells (CAR-T) and T Cell Receptor (TCR) T cells have emerged as a promising cancer therapy. To date, four anti-CD19 CAR-T and one anti-BCMA CAR-T products have been approved by the FDA f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a55a5aef970f4c64fdc5781a71b8b2a
https://doi.org/10.1158/1538-7445.am2022-5576
https://doi.org/10.1158/1538-7445.am2022-5576
Autor:
Sabine Schlyer, Graeme Milligan, Laura Jenkins, Meritxell Canals, Kate Campbell, Elisa Alvarez-Curto, Sabrina de Munnik
Publikováno v:
British Journal of Pharmacology. 162:733-748
BACKGROUND AND PURPOSE GPR35 is a poorly characterized G protein-coupled receptor at which kynurenic acid has been suggested to be the endogenous ligand. We wished to test this and develop assays appropriate for the study of this receptor. EXPERIMENT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c71d2eb86a53d234a38eb2124393c8bb
https://doi.org/10.1111/j.1476-5381.2010.01082.x
https://doi.org/10.1111/j.1476-5381.2010.01082.x
Autor:
Laura, Jenkins, Elisa, Alvarez-Curto, Kate, Campbell, Sabrina, de Munnik, Meritxell, Canals, Sabine, Schlyer, Graeme, Milligan
Publikováno v:
British journal of pharmacology. 162(3)
GPR35 is a poorly characterized G protein-coupled receptor at which kynurenic acid has been suggested to be the endogenous ligand. We wished to test this and develop assays appropriate for the study of this receptor.Human and rat orthologues of GPR35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c3b7a6378e489d8c1ebef08ee668939
https://pubmed.ncbi.nlm.nih.gov/20958291
https://pubmed.ncbi.nlm.nih.gov/20958291